Accolade Welcomes Renalogic to Trusted Partner Ecosystem

Core Insights - Accolade, Inc. has partnered with Renalogic to enhance chronic kidney disease (CKD) management and reduce dialysis costs for self-insured employers [1][3] - The average cost for employer-sponsored healthcare is projected to reach $16,000 per employee by 2025, with late-stage CKD patients incurring disproportionately high costs [1][3] - Renalogic's solutions aim to improve health outcomes and provide significant cost savings, with dialysis costs averaging$250,000 per member per year [3] Partnership Details - Renalogic will join Accolade's Trusted Partner Ecosystem, focusing on CKD risk management and dialysis cost containment [1][3] - The partnership will facilitate warm handoffs from Accolade Care Advocates to Renalogic's clinical team, promoting awareness of Renalogic's services at no additional cost [3][4] Cost Management Solutions - Renalogic's ImpactIQ uses proprietary data algorithms to identify both diagnosed and undiagnosed CKD members, improving the identification of high-cost claims [2] - The ImpactAdvocate program reduces emergent dialysis starts by 30-50%, potentially saving up to $50,000 per emergent start [2] - Renalogic's ImpactProtect advises on fair market rates for dialysis services, achieving savings of 50-80$75,000 - $125,000 per member annually [2] Company Background - Accolade is a Personalized Healthcare company that provides comprehensive healthcare solutions, achieving consumer satisfaction ratings over 90% [7] - Renalogic, founded in 2002, specializes in managing the costs associated with CKD and dialysis treatment, helping clients save hundreds of millions of dollars [8]